24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Johnson & Johnson
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
08:03
The end-of-year tech layoffs are not a crisis - they mark a paradigm shift
07:29
MSC denies interest in acquiring ZIM
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
More news
Johnson & Johnson
8 stories about Johnson & Johnson
J&J’s $1.7 billion bet on Israeli heart device falters after FDA panel vote
10.12.25
|
CTech
Advisors reject effectiveness of V-Wave’s implant, threatening the contingent value of last year’s acquisition.
Riding the V-Wave exit: Who are the big winners?
21.08.24
|
Meir Orbach
The pharmaceutical giant Johnson & Johnson announced on Tuesday the purchase of the Israeli medical device company for up to $1.7 billion. BRM is the largest shareholder in the company and is expected to receive at least $100 million. The second largest shareholder is Pontifax VC of Tomer Kariv and Ran Nussbaum. Other notable investors include Ilan Grinboim and Prof. Benad Goldwasser.
Johnson & Johnson to acquire Israeli medical device maker V-Wave for up to $1.7 billion
20.08.24
|
Meir Orbach
V-Wave's device is implanted in the heart through a minimally invasive procedure to help reduce heart failure and other events.
Place your bets: Which company will reach a Covid-19 vaccine first?
02.08.20
|
Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
Orthopedic Brace Startup OrthoSpin Raises $5 Million
31.03.20
|
Adi Pick
OrthoSpin develops an electric brace designed to help with bone lengthening, setting complex fractures, and correcting deformities
Zebra Medical Partners With Johnson & Johnson Subsidiary
19.12.19
|
Meir Orbach
DePuy Synthes, a subsidiary of Johnson & Johnson, develops surgical devices used to treat fractures and orthopedic injuries
Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen
24.04.19
|
CTech
The two companies will collaborate on the research of a “therapeutic area of mutual interest”
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics